Notably, histopathological analysis revealed the enhanced tau pathologies observed in the drug users were analogous to the pathological tau found in AD and CTE, but as in the case of CTE, the distribution was determined to be distinct from classical AD progression. The gene discussed is MAPT; the disease is Alzheimer disease.